Girihlet Competitors and Similar CompaniesClear all

Girihlet's competitors and similar companies include Cell Matters, Aurion Biotech, Bolt Biotherapeutics and Pluri Biotech.

	Girihlet Girihlet is a biotechnology company that provides disease monitoring and strategic therapeutic solutions for immune systems.	Cell Matters Cell Matters is a biotechnology company that increases the effectiveness of cell therapy by offering an integrated suite of GMP-compliant services.	Aurion Biotech Aurion Biotech is a clinical stage biotech company that develops a platform of therapies to cure blindness.	Bolt Biotherapeutics Bolt Biotherapeutics is a biotechnology company developing immunotherapeutics for multiple types of cancer.	Pluri Biotech Pluri Biotech (פלורי ביוטק בע"מ, formerly Pluristem Therapeutics) is a clinical-stage biotherapy company developing cell therapies.
Founding Date	Founding Date 2016	Founding Date 2017	Founding Date 2021	Founding Date 2015	Founding Date 2003
Type	Type Private	Type Private	Type Private	Type Public	Type Public
Tags	Tags Technology biotech monitoring platform therapy	Tags Technology biotech compliance platform therapy	Tags Technology biotech healthtech platform therapy	Tags Technology biotech oncology platform therapy	Tags Technology biotech platform therapy
Locations	Locations Oakland, US HQ Oakland, US	Locations Liège, BE HQ	Locations Seattle, US HQ	Locations Redwood City, US HQ	Locations Haifa, IL HQ Potsdam, DE
Employees	Employees 2	Employees 8	Employees 901% decrease	Employees 5248% decrease	Employees 106
Valuation ($)	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 25.6 m	Valuation ($) 25.2 m
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) $7.7m (FY, 2025)	Revenue (est.) $1.3m (FY, 2025)
Net income	Net income N/A	Net income N/A	Net income N/A	Net income ($33.4m) (FY, 2025)	Net income ($23.3m) (FY, 2025)
Funding
Latest funding round	Latest funding round $ 2.5m (over 7 years ago)	Latest funding round N/A	Latest funding round $ 120m (about 4 years ago)	Latest funding round N/A	Latest funding round N/A
Total funding raised	Total funding raised $ 2.8m	Total funding raised N/A	Total funding raised $ 120m	Total funding raised $ 177.5m	Total funding raised $ 78.4m